How does Eltrombopag 50 mg help increase platelet count?
Eltrombopag 50 mg helps increase platelet count by stimulating the bone marrow to make more platelets. It activates a specific receptor called the thrombopoietin receptor, which signals the bone marrow to produce platelets. This is especially helpful in people with chronic immune thrombocytopenia (ITP) or other conditions where the body cannot make enough platelets. By raising platelet levels, Eltrombopag helps reduce the risk of bleeding and bruising. It is not a blood product or transfusion—it works by helping your body naturally make platelets. Patients usually see a rise in platelet count after a few weeks of use.
Can Eltrombopag 50 mg reduce the need for platelet transfusions?
Yes, Eltrombopag 50 mg can reduce the need for platelet transfusions. It helps your body produce more of its own platelets, especially in patients with chronic ITP, severe aplastic anemia, or low platelet levels caused by hepatitis C. By raising platelet counts naturally, it lowers the risk of dangerous bleeding without relying on transfusions. This is important for people who receive frequent treatments or for those who do not respond well to transfusions. Eltrombopag provides a safer, long-term way to manage low platelet counts and may also improve quality of life by avoiding repeated hospital visits.
Is Eltrombopag 50 mg useful in treating severe aplastic anemia?
Yes, Eltrombopag 50 mg is useful in treating severe aplastic anemia (SAA). This condition happens when the bone marrow fails to produce enough blood cells, including platelets. Eltrombopag helps by stimulating the bone marrow to create more platelets and other blood cells. It is often used when patients do not respond well to immunosuppressive therapy or need additional support to restore blood counts. In many cases, patients taking Eltrombopag see improvements in platelet count and other blood components, reducing their need for transfusions. Always follow your doctor’s advice while using this medication for SAA.
Does Eltrombopag 50 mg help patients with hepatitis C-related thrombocytopenia?
Yes, Eltrombopag 50 mg is effective for treating hepatitis C-related thrombocytopenia, a condition where platelet counts drop due to the virus or its treatment. Low platelet levels in these patients can delay or prevent antiviral therapy. Eltrombopag helps raise platelet counts so patients can start or continue hepatitis C treatment safely. It works by activating receptors in the bone marrow to boost platelet production naturally. This reduces bleeding risks and improves overall treatment outcomes. Doctors often prescribe it before or during antiviral treatment to keep platelet levels stable without needing platelet transfusions.
How much does Eltrombopag 50 mg cost Without Insurance?
The cost of Eltrombopag 50 mg without insurance can be high. On average, a single tablet may cost between $250 to $400, and a monthly supply may exceed $8,000 depending on the pharmacy and brand. Generic versions may be available at a lower cost. Prices can vary, so comparing different pharmacies or using discount programs can help reduce expenses. Some pharmaceutical companies or health organizations also offer patient assistance programs for those who qualify. Always consult your healthcare provider or pharmacist for the best price options and whether cost-saving programs are available to you.
